Insiders · Profile

Parrot David

Chief Financial Officer at Scribe Therapeutics. Filing since 23 Jul 2026. CIK 0002127908

Company
Date
Role
Action
Shares
Amount
Of holding
23 Jul 2026
Chief Financial Officer
Bought
2,666
$39.99K
opened
1 decision on file.